Marinus Pharmaceuticals
Marinus Pharmaceuticals is dedicated to developing innovative therapies for neurological disorders, with a focus on epilepsy and other serious conditions. Their mission is to improve the lives of patients through scientific research and clinical development.
Industries
Nr. of Employees
medium (51-250)
Marinus Pharmaceuticals
Branford, Connecticut, United States, North America
Patents
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders
US-12268696-B2
View DetailsGanaxolone for use in treating tuberous sclerosis complex and seizure disorders
US-12115169-B2
View Details
Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders
US-12268696-B2
View DetailsGanaxolone for use in treating tuberous sclerosis complex and seizure disorders
US-12115169-B2
View DetailsProducts
Investigational neuroactive therapeutic for epilepsy-related disorders
An investigational neuroactive therapeutic candidate under clinical development for treatment of seizures and epilepsy-related rare disorders (pipeline references to multiple indications).
Investigational neuroactive therapeutic for epilepsy-related disorders
An investigational neuroactive therapeutic candidate under clinical development for treatment of seizures and epilepsy-related rare disorders (pipeline references to multiple indications).
Services
Medical-scientific engagement, clinical information dissemination, and poster/publication support for clinical stakeholders.
Administration of pre-approval/patient access programs for investigational therapies.
Support mechanisms for external investigators conducting studies using investigational agents.
Telehealth services and remote patient engagement to support treatment access and monitoring.
Medical-scientific engagement, clinical information dissemination, and poster/publication support for clinical stakeholders.
Administration of pre-approval/patient access programs for investigational therapies.
Support mechanisms for external investigators conducting studies using investigational agents.
Telehealth services and remote patient engagement to support treatment access and monitoring.
Expertise Areas
- Clinical trial management (neurology)
- Rare disease and epilepsy therapeutics development
- Managed access and compassionate use programs
- Medical affairs and scientific communications
Key Technologies
- Neuroactive therapeutic development (small-molecule/investigational therapeutics)
- Clinical development platform for neurology indications
- Telehealth delivery for patient support
- Managed access program processes